Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer.

Saved in:
Bibliographic Details
Title: Phase II study of belotecan, a camptothecin analogue, in combination with carboplatin for the treatment of recurrent ovarian cancer.
Authors: Chel Hun Choi1, Yoo-Young Lee1, Tae-Jong Song1, Hwang-Shin Park1, Min Kyu Kim1, Tae-Joong Kim1, Jeong-Won Lee1, Je-Ho Lee1, Duk-Soo Bae1, Byoung-Gie Kim1
Source: Cancer (0008543X). 5/15/2011, Vol. 117 Issue 10, p2104-2111. 8p. 6 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:0008543X
DOI:10.1002/cncr.25710